Dear Colleagues,

Enzymes play a pivotal role within the realm of drug development across the pharmaceutical landscape. At the heart of this endeavor lies the complicated interplay between molecules and proteins, that must be unraveled to understand their multifaceted reactions. Numerous analytical methodologies are necessary to define their mechanisms of action. This involves the understanding of purification paradigms, kinetics dissection, protein stabilization methodologies, and the optimization of crucial parameters such as pH, temperature, and ionic strength. Furthermore it is necessary to learn about substrate-product binding dynamics, ligand and protein interactions, the revelation of three-dimensional structural nuances, and the transformative contours defined by conformational variations.

A recent seismic shift has transformed this landscape with the advent of in silico analysis. This catalytic leap has propelled the study of enzyme characterization to new heights. The mechanisms of molecular docking and molecular dynamics play a pivotal role in this transformative process. Our Special Issue serves as a symposium of new ideas to better understand the profound interactions between enzymes and proteins in the development of new drugs to treat various diseases in clinical practice.

Prof. Sung-Kun Kim
Guest Editor